Richard P. Slaughter Associates’s Pfizer PFE Stock Holding History

Richard P. Slaughter Associates’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-129,355	Closed	-$3.43M	–	151
2024 Q4	$3.43M	Sell	129,355 -8,016	-6%	-$217K	0.77%	29
2024 Q3	$3.98M	Sell	137,371 -19,561	-12%	-$571K	0.92%	24
2024 Q2	$4.39M	Buy	156,932 +10,808	+7%	+$298K	1.04%	22
2024 Q1	$4.05M	Buy	146,124 +37,754	+35%	+$1.05M	0.97%	22
2023 Q4	$3.12M	Buy	108,370 +551	+0.5%	+$16.7K	0.77%	25
2023 Q3	$3.58M	Buy	107,819 +59,821	+125%	+$2.12M	0.95%	19
2023 Q2	$1.76M	Buy	47,998 +3,143	+7%	+$122K	0.5%	55
2023 Q1	$1.83M	Buy	44,855 +1,444	+3%	+$62.4K	0.6%	47
2022 Q4	$2.22M	Buy	43,411 +1,555	+4%	+$74.6K	0.7%	43
2022 Q3	$1.83M	Buy	+41,856	New	+$2.03M	0.77%	43
2021 Q4	–	Sell	-4,789	Closed	-$205K	–	130
2021 Q3	$205K	Buy	+4,789	New	+$212K	0.08%	119

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Richard P. Slaughter Associates's PFE Position: Q1 2025 in Review

Richard P. Slaughter Associates sold out of Pfizer (PFE) in Q1 2025, closing a stake of 129,355 shares — an estimated $3.43M sold.

Richard P. Slaughter Associates first reported a position in PFE in Q3 2021 and held it in 11 quarters. The position peaked at $4.39M in Q2 2024. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

Richard P. Slaughter Associates reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
Richard P. Slaughter Associates sold 129,355 Pfizer shares in Q1 2025, an estimated $3.43M.
Richard P. Slaughter Associates first reported a position in Pfizer in Q3 2021 and held it in 11 quarters.
Richard P. Slaughter Associates's Pfizer position peaked at $4.39M in Q2 2024.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Richard P. Slaughter Associates's 13F filing for Q1 2025, filed 10 Apr 2025.